Navigation Links
MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen

Data published today in the Journal of the National Cancer Institute

BASEL, Switzerland, 2 May 2007 - In a study published today in the Journal of the National Cancer Institute, the innovative cancer drug MabThera was shown to improve overall survival in patients with lymphoma regardless of the chemotherapy regimen used.1 The review further stated that the improvement in survival was seen for the first time in patients with mantle cell lymphoma, a rare, aggressive form of lymphoma.

The study was a comprehensive, systematic meta-analysis review of newly-diagnosed or relapsed patients involved in trials that compared MabThera treatment regimens with chemotherapy alone. The review not only demonstrated improved overall survival with MabThera but also that disease control in the MabThera containing arms of the trials was significantly superior to chemotherapy alone.

"This meta analysis clearly demonstrates the contribution MabThera makes to the management of patients with indolent lymphoma," commented Prof. Andreas Engert, from the Cochrane Hematological Malignacies Group, University of Cologne, and one of the authors of the study. "The results confirm the addition of MabThera to treatment of patients with two major forms of NHL extends patients' lives, regardless of their chemotherapy regimen."

Non-Hodgkin's lymphoma (NHL) affects 1 million people worldwide. It is estimated that 360,000 people die each year from the disease.2 Indolent NHL, representing about 45% of NHL patients, is a slow developing but serious cancer of the lymphatic system.

About the study The study included only randomized controlled trials (RCT) comparing R-chemo with chemotherapy alone in patients with newly diagnosed or relapsed indolent lymphoma and mantle cell lymphoma (MCL). Medical databases (Cochrane Library, MEDLINE, EMBA
'"/>




Page: 1 2 3 4

Related medicine technology :

1. MabThera Significantly Extends Survival And Cures More Patients With Aggressive Lymphoma Than Chemotherapy Alone
2. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients

Post Your Comments:
(Date:11/6/2009)...a., Nov. 6 In consultation with th...Consumer Healthcare, Division of McNEIL-PPC, Inc.,...ber of product lots of TYLENOL® Arthritis Pai...ed EZ-OPEN CAP. McNeil is initiating the recall af... associated with these lots that led to a small nu...
(Date:11/6/2009)...wswire/ -- Repossessions and liquidations of truck...er of 2009 declined as compared to similar figures... NasTrac Quarterly Index (NQI). The figures, cull...possessions and orderly liquidations, also indicat...nd printing equipment, offering mixed news on the ...
(Date:11/6/2009)...ewswire-FirstCall/ -- Derma Sciences, Inc. (OT...und care products, announced plans to release its ..., November 16, 2009. The Company will hold a confe... 11:00 am EST. Interested parties should call (866...onal), with passcode 81416481 to access the call. ...
Breaking Medicine Technology:McNeil Consumer Healthcare Announces Voluntary Recall of Certain Lots of TYLENOL(R) Arthritis Pain 100 Count with EZ-OPEN CAP 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 2NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 3NasTrac Quarterly Index Shows Decline in Trucking and Machine Tool Repossessions in Q3 2009 4Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Just Released New Poll 3A Healthcare Through Womens Eyes 60259 1Just Released New Poll 3A Healthcare Through Womens Eyes 60259 2Webmedx Reacts to News of Confidential Medical Records Being Sold on the Black Market 60255 1Webmedx Reacts to News of Confidential Medical Records Being Sold on the Black Market 60255 2VitaminSpice Appoints Dr Richard F Seelig as Director 5795 1VitaminSpice Appoints Dr Richard F Seelig as Director 5795 2
...25 Findings from an international,multicenter, ra... trial,evaluating ustekinumab (CNTO 1275) in the t...ll be presented for the first time at the 21st mee...akes place from Sept. 30 to,Oct. 5, 2007 in Buenos...O 1275 (anti-IL-12/23p40) Treatment of,Psoriasis: ...
...Drug,s Benefit, Alone and With Lipitor(R), in, O...and Triglycerides -, HAYWARD, Calif., Sept. 25 M...to the discovery and development of novel,therapeu... announced today,that it has begun a 180-patient P...tients with high cholesterol and triglycerides to ...
Other Medicine Technology:Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting 2Metabolex Begins Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia 2
(Date:11/8/2009)...wire/ -- Tonight the House of Representatives pass...dmark health reform legislation that will ensure e...table and secure health care coverage. The legisla...ndustry,s worst practices, would extend coverage t... billion over ten years. Groups representing docto...
(Date:11/8/2009)...biopharmaceuticals to be available at the Company&... Toronto, ON (PRWEB) November 8, 2...ure Biopharma Inc. today announced that the Compan...eutical grade freeze dryer and expects to make com...able for contract manufacturing of biopharmaceutic...
(Date:11/8/2009)...wire/ -- Today, the House of Representatives passe...lsworth and Lipinski amendment to the "Affordable ...dment maintains the current policy of preventing f...ges that include abortion. It clarifies that indiv...ts and those who do not, can with their own funds ...
(Date:11/8/2009)...wire/ -- USAction this evening hailed passage of t...ill make health care more affordable for consumers...e access to health care for millions of Americans ...DR and Harry Truman would be proud," said USAction...s among our country,s proudest achievements. Today...
(Date:11/8/2009)...wire/ -- The following was released today by Randa...x. ,, Mr. Terry and his associates from around...ing by abortion out of any health care bill for mo...st step to victory -- a touchdown in the first qua... Our rejoicing must be tempered by reality. The Se...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 2Health News:Democratic National Committee Chairman Tim Kaine Issues Statement Praising the House of Representative's Historic Vote to Pass Health Insurance Reform 3Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2
...N, Feb. 6 The U.S. Agency for,International Devel...y of,Zero Tolerance for Female Genital Cutting (FG... First Lady of the Federal Republic of Nigeria,spe...practice., Approximately 100 million to 140 milli...
...IS, Feb. 6 Worrell Inc., a full-service,product d...Shanghai, has,acquired the Montreal and San Diego ...ges Worrell Inc.,s industrial design prowess with ...ell. "We know how this business works. The Gad,Sha...
... currently expected to be February 21, 2008 ...ceived - Class action lawsuit settled...n Therapy,Services, Inc. (Nasdaq: RTSX ) (the "Co...d as of October 19, 2007 among,the Company, Radiat...
...f the Red Cross Annual Disaster Giving Program Pro...re weather and,tornadoes ripped through the South ...ommunities in Arkansas, Kentucky, Tennessee, Alaba...shelter, feeding victims and search and rescue wor...
..., Mass. (February 6, 2008)Perhaps the only positiv...a is that its relatively uncommon. Other than that...ends to strike people in the prime of their lives,...is poorly understood type of cancer. , One appro...
...N, Feb. 6 The Lupus Foundation of,America (LFA) i...atient,education series. Five new booklets and ele... information about lupus diagnosis and treatment.,... individuals and families. Developed in consultati...
Other Medicine News:Health News:From Kent Hill, USAID Assistant Administrator for Global Health on the Observance of International Day of Zero Tolerance 2Health News:Radiation Therapy Services, Inc. Shareholders Approve Merger Agreement 2Health News:Radiation Therapy Services, Inc. Shareholders Approve Merger Agreement 3Health News:American Red Cross Responds to Tornadoes in the Southeast 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 2Health News:Gene plays 'Jekyll and Hyde' in brain cancer 3Health News:Lupus Foundation of America Releases New Patient Education Series 2
...he widest offering of single-use instruments on th...long 43cm lengths for Bariatric Surgery. , Dual a...sulation covers the pivot points to reduce the cha...cord, which eliminates gapping at connection and t...
MultAcoice™™ Rongeur Handle With Ratchet and Monopolar Cautery
MultAcoice™ 5 mm Insulated Outer Shaft
...order products are offered as 1-piece or modular, ...ruments may be customized with handles of choice a...flush ports. Many standard patterns are available ...ffect delivery times. , Please Note: Individual ...
Medicine Products: